Semler Scientific® Reports Fourth Quarter and Full Year 2024 Financial Results with a BTC Yield of 107% since July 1, 2024; Now holds 3,192 BTC
Semler Scientific (SMLR) reported its Q4 and full-year 2024 financial results, highlighting a significant shift in strategy towards bitcoin treasury. The company holds 3,192 bitcoins valued at approximately $300 million, acquired through operating cashflow and various financing methods.
For FY2024, SMLR reported revenues of $56.3 million, a 17% decrease from 2023's $68.2 million. Income from operations was $20.9 million, down 6% year-over-year. Net income increased 99% to $40.9 million, including a $24.9 million unrealized gain from bitcoin holdings.
The company raised funds through an ATM offering, selling 2,197,988 shares for net proceeds of $119.6 million, and issued $100 million in convertible notes. SMLR's BTC Yield KPI reached 107% since July 2024, reflecting the company's strategic pivot to bitcoin accumulation as a means to maximize stockholder value.
Semler Scientific (SMLR) ha pubblicato i risultati finanziari del quarto trimestre e dell'intero anno 2024, evidenziando un cambiamento significativo nella strategia verso il tesoro di bitcoin. L'azienda detiene 3.192 bitcoin valutati circa 300 milioni di dollari, acquisiti attraverso il flusso di cassa operativo e vari metodi di finanziamento.
Per l'anno fiscale 2024, SMLR ha riportato ricavi di 56,3 milioni di dollari, con una diminuzione del 17% rispetto ai 68,2 milioni di dollari del 2023. Il reddito operativo è stato di 20,9 milioni di dollari, in calo del 6% rispetto all'anno precedente. L'utile netto è aumentato del 99% a 40,9 milioni di dollari, inclusi 24,9 milioni di dollari di guadagno non realizzato dalle partecipazioni in bitcoin.
L'azienda ha raccolto fondi attraverso un'offerta di ATM, vendendo 2.197.988 azioni per proventi netti di 119,6 milioni di dollari, e ha emesso 100 milioni di dollari in note convertibili. Il KPI del rendimento BTC di SMLR ha raggiunto il 107% da luglio 2024, riflettendo il cambiamento strategico dell'azienda verso l'accumulo di bitcoin come mezzo per massimizzare il valore per gli azionisti.
Semler Scientific (SMLR) informó sus resultados financieros del cuarto trimestre y del año completo 2024, destacando un cambio significativo en la estrategia hacia el tesoro de bitcoin. La compañía posee 3,192 bitcoins valorados en aproximadamente 300 millones de dólares, adquiridos a través de flujo de efectivo operativo y diversos métodos de financiamiento.
Para el año fiscal 2024, SMLR reportó ingresos de 56.3 millones de dólares, una disminución del 17% respecto a los 68.2 millones de dólares de 2023. El ingreso de operaciones fue de 20.9 millones de dólares, una caída del 6% en comparación con el año anterior. El ingreso neto aumentó un 99% a 40.9 millones de dólares, incluyendo una ganancia no realizada de 24.9 millones de dólares de las tenencias de bitcoin.
La compañía recaudó fondos a través de una oferta de cajero automático, vendiendo 2,197,988 acciones por ingresos netos de 119.6 millones de dólares, y emitió 100 millones de dólares en notas convertibles. El KPI de rendimiento de BTC de SMLR alcanzó el 107% desde julio de 2024, reflejando el cambio estratégico de la compañía hacia la acumulación de bitcoin como un medio para maximizar el valor para los accionistas.
Semler Scientific (SMLR)는 2024년 4분기 및 연간 재무 결과를 발표하며 비트코인 재무 전략으로의 중요한 전환을 강조했습니다. 이 회사는 운영 현금 흐름과 다양한 자금 조달 방법을 통해 약 3억 달러에 해당하는 3,192개의 비트코인을 보유하고 있습니다.
2024 회계연도에 대해 SMLR은 5,630만 달러의 수익을 보고했으며, 이는 2023년의 6,820만 달러에 비해 17% 감소한 수치입니다. 운영 소득은 2,090만 달러로, 전년 대비 6% 감소했습니다. 순이익은 99% 증가하여 4,090만 달러에 달했으며, 여기에는 비트코인 보유로 인한 2,490만 달러의 미실현 이익이 포함됩니다.
회사는 ATM 공모를 통해 자금을 조달했으며, 2,197,988주를 판매하여 1억 1,960만 달러의 순수익을 올렸고, 1억 달러의 전환사채를 발행했습니다. SMLR의 BTC 수익 KPI는 2024년 7월 이후 107%에 도달하여 주주 가치를 극대화하기 위한 비트코인 축적 전략의 전환을 반영하고 있습니다.
Semler Scientific (SMLR) a publié ses résultats financiers du quatrième trimestre et de l'année complète 2024, mettant en évidence un changement significatif de stratégie vers le trésor bitcoin. L'entreprise détient 3 192 bitcoins d'une valeur d'environ 300 millions de dollars, acquis grâce à un flux de trésorerie opérationnel et à divers moyens de financement.
Pour l'exercice 2024, SMLR a annoncé des revenus de 56,3 millions de dollars, soit une diminution de 17 % par rapport aux 68,2 millions de dollars de 2023. Le revenu d'exploitation s'est élevé à 20,9 millions de dollars, en baisse de 6 % par rapport à l'année précédente. Le revenu net a augmenté de 99 % pour atteindre 40,9 millions de dollars, incluant un gain non réalisé de 24,9 millions de dollars provenant des avoirs en bitcoin.
L'entreprise a levé des fonds par le biais d'une offre d'ATM, vendant 2 197 988 actions pour des produits nets de 119,6 millions de dollars, et a émis 100 millions de dollars en obligations convertibles. Le KPI de rendement BTC de SMLR a atteint 107 % depuis juillet 2024, reflétant le changement stratégique de l'entreprise vers l'accumulation de bitcoins comme moyen de maximiser la valeur pour les actionnaires.
Semler Scientific (SMLR) hat seine Finanzzahlen für das vierte Quartal und das gesamte Jahr 2024 veröffentlicht und dabei einen signifikanten Strategiewechsel hin zu Bitcoin-Reserven hervorgehoben. Das Unternehmen hält 3.192 Bitcoins im Wert von etwa 300 Millionen Dollar, die durch operativen Cashflow und verschiedene Finanzierungswege erworben wurden.
Für das Geschäftsjahr 2024 meldete SMLR Einnahmen von 56,3 Millionen Dollar, was einem Rückgang von 17 % im Vergleich zu 68,2 Millionen Dollar im Jahr 2023 entspricht. Der operative Gewinn betrug 20,9 Millionen Dollar, ein Rückgang um 6 % im Jahresvergleich. Der Nettogewinn stieg um 99 % auf 40,9 Millionen Dollar, einschließlich eines nicht realisierten Gewinns von 24,9 Millionen Dollar aus Bitcoin-Beständen.
Das Unternehmen hat durch ein ATM-Angebot Kapital beschafft, indem es 2.197.988 Aktien für einen Nettobetrag von 119,6 Millionen Dollar verkauft hat, und hat 100 Millionen Dollar in wandelbaren Anleihen ausgegeben. Der BTC-Performance-KPI von SMLR erreichte seit Juli 2024 107 %, was den strategischen Wechsel des Unternehmens zur Bitcoin-Akkumulation zur Maximierung des Aktionärswerts widerspiegelt.
- Net income increased 99% to $40.9 million in 2024
- Unrealized gain of $24.9 million from bitcoin holdings
- Successful capital raising: $119.6M from ATM offering and $100M from convertible notes
- Strong bitcoin position with 3,192 BTC valued at ~$300 million
- Market capitalization increased over 200% since implementing bitcoin strategy
- Revenue decreased 17% to $56.3 million in 2024
- Income from operations declined 6% to $20.9 million
- High customer concentration with top two customers representing 71% of revenue
- Cash and cash equivalents decreased from $57.2M to $8.8M
Insights
The financial results present a complex picture of Semler Scientific's strategic transformation in 2024. While the core healthcare technology business experienced a 17% revenue decline to
The most significant development is the aggressive pivot to a bitcoin treasury strategy. Through a well-executed capital raising program, Semler has secured
Several risk factors warrant attention:
- Customer Concentration: Two clients account for
71% of total revenue, creating significant dependency risk - Operating Focus: The shift to bitcoin treasury management could divert attention from the core healthcare business
- Balance Sheet Transformation: Digital assets now represent
89% of total assets, fundamentally altering the company's risk profile - Debt Service: Annual interest expense of approximately
$4.25 million from the convertible notes adds a new fixed obligation
The bitcoin treasury strategy has yielded impressive paper gains, with
The company's ability to generate
"We are again pleased to report strong performance from our healthcare business with income from operations of
"2024 was a transformative year for Semler Scientific as we embraced a bitcoin treasury strategy to maximize stockholder value," said Eric Semler, chairman of Semler Scientific. "Through a disciplined and accretive approach, we have acquired 3,192 bitcoins, which are now valued at approximately
BITCOIN TREASURY HIGHLIGHTS AND OTHER RECENT DEVELOPMENTS
- "BTC Yield" KPI: For the year ended December 31, 2024, Semler Scientific's BTC Yield was
107% . BTC Yield is a key performance indicator (KPI) that Semler Scientific uses to help assess the performance of its strategy of acquiring bitcoin in a manner it believes is accretive to stockholders. See "Important Information about BTC Yield KPI" in this press release for the definition of BTC Yield and how it is calculated. - Digital Assets: As of December 31, 2024, Semler Scientific held 2,298 bitcoins with a fair value of
$214.6 million $24.9 million $189.7 million $90.7 million $280.4 million - At-the-Market Equity Offering Program: Semler Scientific entered into a Controlled Equity Offeringsm Sales Agreement (the Sales Agreement) with Cantor Fitzgerald & Co., pursuant to which it may issue and sell from time to time up to
$150.0 million $119.6 million - Issuance of
4.25% Convertible Notes due 2030: In January 2025, Semler Scientific issued$100.0 million 4.25% Convertible Senior Notes due 2030 (the Notes), including the exercise in full of the initial purchasers' option to purchase up to an additional$15.0 million $76.44 $107.01
FINANCIAL RESULTS
For the year ended December 31, 2024, compared to the corresponding period of 2023, Semler Scientific reported:
- Revenues of
$56.3 million $11.9 million 17% , compared to$68.2 million - Cost of revenues of
$4.8 million $2.2 million 32% compared to$7.0 million $2.5 million - Total operating expenses, which includes cost of revenues, of
$35.4 million $10.5 million 23% , compared to$45.9 million - Income from operations of
$20.9 million $1.4 million 6% , compared to$22.3 million - Pre-tax income of
$47.9 million $24.9 million $23.8 million 99% , compared to$24.1 million - Income tax expense of
$7.0 million 15% , compared to$3.5 million 15% . - Net income of
$40.9 million $5.66 $5.13 $20.3 million 99% , compared to$20.6 million $3.06 $2.63
Semler Scientific's two largest customers (including their affiliates) comprised
For the fourth quarter ended December 31, 2024, compared to the corresponding period of 2023, Semler Scientific reported:
- Revenues of
$12.4 million $2.7 million 18% , compared to$15.1 million - Cost of revenues of
$1.1 million $2.3 million 67% , compared to$3.4 million $2.5 million - Total operating expenses, which include cost of revenues, of
$8.9 million $3.6 million 29% , compared to$12.5 million - Income from operations of
$3.5 million $1.0 million 40% , compared to$2.5 million - Pre-tax income of
$32.6 million $28.8 million $29.8 million 058% , compared to$2.8 million - Income tax expense of
$3.4 million 10% , compared to income tax benefit of$1.4 million 50% . - Net income of
$29.2 million $3.64 $3.41 $25.0 million 592% , compared to net income of$4.2 million $0.62 $0.55
Semler Scientific's two largest customers (including their affiliates) comprised
Notice of Conference Call
Semler Scientific will host a conference call today at 4:30 p.m. ET. The call will address results of the fourth quarter and year ended December 31, 2024, as well as provide a business update on Semler Scientific's strategies for the near-term future. Questions can be submitted prior to the start of the call to ir@semlerscientific.com.
Participants are encouraged to pre-register for the conference call using the following link: https://dpregister.com/sreg/10196221/fe5ab5166e. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or who are unable to pre-register may dial in by calling:
Domestic callers: (833) 816–1161
International callers: (412) 317–0717
Please specify to the operator that you would like to join the "Semler Scientific Call." The conference call will be archived on Semler Scientific's website at www.semlerscientific.com.
Semler Scientific, Inc. Statements of Income (In thousands of | ||||||||||||
For the three months ended December 31, | For the year ended December 31, | |||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||
Unaudited | Unaudited | |||||||||||
Revenues | $ | 12,413 | $ | 15,056 | $ | 56,294 | $ | 68,184 | ||||
Operating expenses: | ||||||||||||
Cost of revenues | 1,102 | 3,384 | 4,759 | 6,984 | ||||||||
Engineering and product development | 1,028 | 1,207 | 4,792 | 5,773 | ||||||||
Sales and marketing | 2,971 | 4,546 | 13,078 | 18,147 | ||||||||
General and administrative | 3,770 | 3,262 | 12,732 | 14,290 | ||||||||
Strategic streamlining | — | 135 | — | 734 | ||||||||
Total operating expenses | 8,871 | 12,534 | 35,361 | 45,928 | ||||||||
Income from operations | 3,542 | 2,522 | 20,933 | 22,256 | ||||||||
Interest and dividend income, net | 179 | 699 | 1,877 | 2,471 | ||||||||
Impairment of investments | — | (337) | — | (337) | ||||||||
Change in fair value of notes held for investment | — | (90) | 128 | (307) | ||||||||
Change in fair value of digital assets | 28,850 | — | 24,933 | — | ||||||||
Other income | 5 | 20 | 13 | 17 | ||||||||
Other income, net | 29,034 | 292 | 26,951 | 1,844 | ||||||||
Pre-tax income | 32,576 | 2,814 | 47,884 | 24,100 | ||||||||
Income tax provision | 3,370 | (1,407) | 6,985 | 3,517 | ||||||||
Net income | $ | 29,206 | $ | 4,221 | $ | 40,899 | $ | 20,583 | ||||
Net income per share, basic | $ | 3.64 | $ | 0.62 | $ | 5.66 | $ | 3.06 | ||||
Weighted average number of shares used in computing basic net income per share | 8,033,757 | 6,804,998 | 7,228,961 | 6,732,806 | ||||||||
Net income per share, diluted | $ | 3.41 | $ | 0.55 | $ | 5.13 | $ | 2.63 | ||||
Weighted average number of shares used in computing diluted net income per share | 8,566,619 | 7,734,263 | 7,980,118 | 7,819,159 | ||||||||
Semler Scientific, Inc. Balance Sheets (In thousands of | ||||||
December 31, | December 31, | |||||
2024 | 2023 | |||||
Assets | ||||||
Current Assets: | ||||||
Cash and cash equivalents | $ | 8,819 | $ | 57,200 | ||
Restricted cash | 133 | 132 | ||||
Trade accounts receivable, net of allowance for credit losses of | 4,378 | 6,125 | ||||
Short-term notes held for investment | 6,100 | — | ||||
Inventory, net | 358 | 445 | ||||
Prepaid expenses and other current assets | 2,900 | 2,042 | ||||
Total current assets | 22,688 | 65,944 | ||||
Assets for lease, net | 1,423 | 2,285 | ||||
Property and equipment, net | 487 | 720 | ||||
Long-term investments | 512 | 512 | ||||
Notes held for investment | — | 5,372 | ||||
Intangible digital assets | 214,633 | — | ||||
Other non-current assets | 85 | 270 | ||||
Deferred tax assets | — | 2,962 | ||||
Total assets | $ | 239,828 | $ | 78,065 | ||
Liabilities and Stockholders' Equity | ||||||
Current liabilities: | ||||||
Accounts payable | $ | 140 | $ | 402 | ||
Accrued expenses | 5,173 | 4,502 | ||||
Deferred revenue | 774 | 1,120 | ||||
Other short-term liabilities | 226 | 176 | ||||
Total current liabilities | 6,313 | 6,200 | ||||
Long-term liabilities: | ||||||
Deferred tax liability | 2,765 | — | ||||
Other long-term liabilities | — | 70 | ||||
Total long-term liabilities | 2,765 | 70 | ||||
Commitments and contingencies | ||||||
Stockholders' equity: | ||||||
Common stock, issued, and 9,556,486 and 6,885,019 shares outstanding (treasury shares of 214,422 and 214,422), respectively | 9 | 7 | ||||
Additional paid-in capital | 130,039 | 11,985 | ||||
Retained earnings | 100,702 | 59,803 | ||||
Total stockholders' equity | 230,750 | 71,795 | ||||
Total liabilities and stockholders' equity | $ | 239,828 | $ | 78,065 | ||
Semler Scientific, Inc. Statements of Cash Flows (In thousands of | ||||||
For the year ended December 31, | ||||||
2024 | 2023 | |||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||
Net income | $ | 40,899 | $ | 20,583 | ||
Reconciliation of Net Income to Net Cash Provided by Operating Activities: | ||||||
Depreciation | 579 | 599 | ||||
Deferred tax expense (income) | 5,727 | (664) | ||||
Loss on disposal of assets for lease | 298 | 369 | ||||
Write off of prepaid software licenses | — | 2,476 | ||||
Gain on short-term investments | — | (151) | ||||
Allowance for credit losses | (88) | 268 | ||||
Change in fair value of notes held for investment | (128) | 307 | ||||
Change in fair value of digital assets | (24,933) | — | ||||
Stock-based compensation | 862 | 944 | ||||
Impairment of long-term investments | — | 337 | ||||
Changes in Operating Assets and Liabilities: | ||||||
Trade accounts receivable | 1,844 | (2,508) | ||||
Inventory | 88 | 24 | ||||
Prepaid expenses and other current assets | (865) | (603) | ||||
Other non-current assets | 85 | 96 | ||||
Accounts payable | (262) | (433) | ||||
Accrued expenses | 671 | (246) | ||||
Other current and non-current liabilities | (367) | (68) | ||||
Net Cash Provided by Operating Activities | 24,410 | 21,330 | ||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||
Additions to property and equipment | (51) | (345) | ||||
Purchase of notes held for investment | (500) | (1,000) | ||||
Purchase of digital assets | (189,700) | — | ||||
Proceeds from maturities of short-term investments | — | 78,093 | ||||
Purchase of short-term investments | — | (57,869) | ||||
Proceeds from sale (purchase) of assets for lease | 269 | (483) | ||||
Net Cash (Used in) Provided by Investing Activities | (189,982) | 18,396 | ||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||
Proceeds from issuance of common stock | 119,602 | — | ||||
Taxes paid related to net settlement of equity awards | (874) | (3,510) | ||||
Common stock warrants acquired | — | (1,949) | ||||
Stock issuance expenses | (3,000) | — | ||||
Proceeds from exercise of stock options | 1,464 | 51 | ||||
Net Cash Provided by (Used in) Financing Activities | 117,192 | (5,408) | ||||
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | (48,380) | 34,318 | ||||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD | 57,332 | 23,014 | ||||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD | $ | 8,952 | $ | 57,332 | ||
Supplemental Disclosure of Cash Flow Information: | ||||||
Cash paid for taxes | $ | 2,260 | $ | 4,060 | ||
Semler Scientific, Inc. Digital Assets- Additional Information Rollforward of bitcoin holdings (in thousands of us dollars, except bitcoin held and price per bitcoin) | |||||||||||||||
Source of | Approximate | ||||||||||||||
Capital | Average | ||||||||||||||
Used to | Purchase | ||||||||||||||
Purchase | Digital Assets | Change in | Digital Assets | Approximate | Price Per | ||||||||||
Bitcoin | at Cost | Fair Value | at Fair Value | Bitcoin Held | Bitcoin (in $) | ||||||||||
Balance as of December 31, 2023 | $ | — | $ | — | $ | — | — | $ | — | ||||||
Digital assets purchased | — | — | — | — | — | ||||||||||
Balance as of March 31, 2024 | — | — | — | — | — | ||||||||||
Digital assets purchased | (a) | 60,000 | — | 60,000 | 877 | 68,436 | |||||||||
Change in fair value of the digital assets | — | (5,055) | (5,055) | — | — | ||||||||||
Balance as of June 30, 2024 | $ | 60,000 | $ | (5,055) | $ | 54,945 | 877 | $ | 68,436 | ||||||
Digital assets purchased | (b) | 8,400 | — | 8,400 | 141 | 59,372 | |||||||||
Change in fair value of the digital assets | — | 1,137 | 1,137 | — | — | ||||||||||
Balance as of September 30, 2024 | $ | 68,400 | $ | (3,918) | $ | 64,482 | 1,018 | $ | 59,372 | ||||||
Digital assets purchased | (b) | 121,300 | — | 121,300 | 1,280 | 94,755 | |||||||||
Change in fair value of the digital assets | — | 28,851 | 28,851 | — | — | ||||||||||
Balance as of December 31, 2024 | $ | 189,700 | $ | 24,933 | $ | 214,633 | 2,298 | $ | 82,538 | ||||||
(a) | Cash from operations |
(b) | Cash from operations and proceeds from ATM offering. |
Important Information about BTC Yield Key Performance Indicator (KPI)
Semler Scientific uses BTC Yield as a KPI to help assess the performance of its strategy of acquiring bitcoin in a manner Semler Scientific believes is accretive to stockholders. Semler Scientific believes this KPI can be used to supplement an investor's understanding of Semler Scientific's decision to fund the purchase of bitcoin by issuing additional shares of its common stock. When Semler Scientific uses this KPI, management also takes into account the various limitations of this metric.
BTC Yield is a KPI that represents the percentage change period-to-period of the ratio between Semler Scientific's bitcoin holdings and its Assumed Diluted Shares Outstanding. Assumed Diluted Shares Outstanding refers to the aggregate of Semler Scientific's actual shares of common stock outstanding as of the end of each period plus all additional shares that would result from the assumed exercise of all outstanding stock option awards. Assumed Diluted Shares Outstanding is not calculated using the treasury method and does not take into account any vesting conditions or the exercise price of any stock option awards.
Additionally, this KPI is not, and should not be understood as, an operating performance measure or a financial or liquidity measure. In particular, BTC Yield is not equivalent to a "yield" in the traditional financial context. It is not a measure of the return on investment Semler Scientific's stockholders may have achieved historically or can achieve in the future by purchasing stock of Semler Scientific, or a measure of income generated by Semler Scientific's operations or its bitcoin holdings, return on investment on its bitcoin holdings, or any other similar financial measure of the performance of its business or assets.
The trading price of Semler Scientific's common stock is informed by numerous factors in addition to the amount of bitcoins Semler Scientific holds and number of actual or potential shares of its stock outstanding. As a result, the market value of Semler Scientific's shares may trade at a discount or a premium relative to the market value of the bitcoin Semler Scientific holds. BTC Yield is not indicative nor predictive of the trading price of Semler Scientific's shares of common stock. As noted above, this KPI is narrow in its purpose and is used by management to assist in assessing whether Semler Scientific is using equity capital in a manner accretive to stockholders solely as it pertains to its bitcoin holdings.
In calculating this KPI, Semler Scientific does not take into account the source of capital used for the acquisition of its bitcoin. Semler Scientific notes in particular, it has acquired bitcoin using cash flow from operations, as well as proceeds from the sale of shares in the ATM offering and sale of the notes. Accordingly, this metric might overstate or understate the accretive nature of Semler Scientific's use of equity capital to buy bitcoin because not all bitcoin may be acquired using proceeds of equity and debt offerings and not all issuances of equity may involve the acquisition of bitcoin.
Semler Scientific's ability to achieve positive BTC Yield may depend on a variety of factors, including its ability to generate cash from operations in excess of its fixed charges and other expenses, as well as factors outside of its control, such as the availability of debt and equity financing on favorable terms. Past performance is not indicative of future results.
Semler Scientific has historically not paid dividends on its shares of common stock, and by presenting this KPI, Semler Scientific makes no suggestion that it intends to do so in the future. Ownership of common stock does not represent an ownership interest in the bitcoin Semler Scientific holds.
Investors should rely on the financial statements and other disclosures contained in Semler Scientific's SEC filings. This KPI is merely a supplement, not a substitute. It should be used only by sophisticated investors who understand its limited purpose and many limitations.
About Semler Scientific, Inc.:
Semler Scientific, Inc. is a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases. Its flagship product, QuantaFlo®, which is patented and cleared by the
Forward-Looking Statements
This press release contains "forward-looking" statements. Such statements can be identified by, among other things, the use of forward-looking language such as the words "believe," "goal," "may," "will," "intend," "expect," "anticipate," "estimate," "project," "would," "could" or words with similar meaning or the negatives of these terms or by the discussion of strategy or intentions. The forward-looking statements in this release include express or implied statements regarding acquiring and holding bitcoin; as well as innovation and growth in its healthcare business; and sales of securities under the Sales Agreement and other financings to support additional bitcoin purchases including the notes and; seeking a new 510(k) clearance for QuantaFlo with expanded indications; among others. Such forward-looking statements are subject to a number of risks and uncertainties that could cause Semler Scientific's actual results to differ materially from those discussed here, such as risks inherent with investing in bitcoin, including bitcoin's volatility; risk of implementing a new bitcoin treasury strategy; risk that insurance plans and other customers will not continue to license its cardiovascular testing products; risk of changes in the reimbursement landscape for its customers including related to the Centers for Medicare and Medicaid Services (CMS) rate announcement; risk of obtaining a new 510(k) clearance for expanded indications; along with those other risk factors detailed in Semler Scientific's filings with the Securities and Exchange Commission. These forward-looking statements involve assumptions, estimates, and uncertainties that reflect current internal projections, expectations or beliefs. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. All forward-looking statements contained in this press release are qualified in their entirety by these cautionary statements and the risk factors described above. Furthermore, all such statements are made as of the date of this press release and Semler Scientific assumes no obligation to update or revise these statements unless otherwise required by law.
No Offer or Solicitation
This press release does not and shall not constitute an offer to sell or a solicitation of an offer to buy any securities of Semler Scientific, Inc., nor shall there be any offer, solicitation or sale of such securities, in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
INVESTOR CONTACT:
Renae Cormier
Chief Financial Officer
ir@semlerscientific.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/semler-scientific-reports-fourth-quarter-and-full-year-2024-financial-results-with-a-btc-yield-of-107-since-july-1--2024-now-holds-3-192-btc-302379320.html
SOURCE Semler Scientific, Inc.
FAQ
What was SMLR's revenue performance in Q4 2024?
How many bitcoins does Semler Scientific (SMLR) hold as of February 2025?
What was SMLR's BTC Yield for 2024?
How much did SMLR raise through its ATM offering in 2024?
What was the impact of SMLR's bitcoin strategy on market capitalization?
